Clinical Research Directory
Browse clinical research sites, groups, and studies.
Trial of JMKX003142 in Participants With Rapidly Progressive Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Sponsor: Jemincare
Summary
A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled Clinical Trial to Evaluate the Efficacy, Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of JMKX003142 in Participants with Rapidly Progressive Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Official title: A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled Clinical Trial to Evaluate the Efficacy, Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of JMKX003142 in Participants With Rapidly Progressive Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Key Details
Gender
All
Age Range
18 Years - 55 Years
Study Type
INTERVENTIONAL
Enrollment
135
Start Date
2025-03-13
Completion Date
2027-05-30
Last Updated
2025-07-03
Healthy Volunteers
No
Interventions
JMKX003142 will be administered orally
JMKX003142 will be administered orally
Plcacebo
matched to JMKX003142
Locations (1)
Peking University First Hospital
Beijing, Beijing Municipality, China